Serina Therapeutics, A Privately-held, Clinical-stage Biotechnology Company Has Agreed To Merge With AgeX Therapeutics In An All-stock Transaction
Portfolio Pulse from Benzinga Newsdesk
Serina Therapeutics, a privately-held, clinical-stage biotechnology company, has agreed to merge with AgeX Therapeutics in an all-stock transaction.
August 30, 2023 | 11:49 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
AgeX Therapeutics is merging with Serina Therapeutics in an all-stock deal. This could potentially increase the value of AgeX's stock.
Mergers often lead to an increase in the stock price of the companies involved due to the potential for increased market share and synergies. As AgeX is merging with Serina, this could potentially increase the value of AgeX's stock.
CONFIDENCE 75
IMPORTANCE 80
RELEVANCE 100